| pubmed-article:17195704 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17195704 | lifeskim:mentions | umls-concept:C0035869 | lld:lifeskim |
| pubmed-article:17195704 | lifeskim:mentions | umls-concept:C0008107 | lld:lifeskim |
| pubmed-article:17195704 | lifeskim:mentions | umls-concept:C0002424 | lld:lifeskim |
| pubmed-article:17195704 | lifeskim:mentions | umls-concept:C0008952 | lld:lifeskim |
| pubmed-article:17195704 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:17195704 | pubmed:dateCreated | 2007-1-1 | lld:pubmed |
| pubmed-article:17195704 | pubmed:abstractText | Incorporation of new rotavirus vaccines into national programs of developing countries will rely on well-designed cost-effective analysis based on accurate assessment of disease burden. For Chile, rotavirus disease burden is determined mostly by outpatient clinic and emergency room visits and by hospitalizations. We previously estimated a yearly incidence of 8000 and 53,000 hospitalizations and emergency room visits respectively for children <or=3 years of age. | lld:pubmed |
| pubmed-article:17195704 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17195704 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17195704 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17195704 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17195704 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:17195704 | pubmed:issn | 0891-3668 | lld:pubmed |
| pubmed-article:17195704 | pubmed:author | pubmed-author:MamaniNoraN | lld:pubmed |
| pubmed-article:17195704 | pubmed:author | pubmed-author:O'RyanMiguelM | lld:pubmed |
| pubmed-article:17195704 | pubmed:author | pubmed-author:DíazJanepsyJ | lld:pubmed |
| pubmed-article:17195704 | pubmed:author | pubmed-author:NavarreteMari... | lld:pubmed |
| pubmed-article:17195704 | pubmed:author | pubmed-author:VallebuonoCle... | lld:pubmed |
| pubmed-article:17195704 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17195704 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:17195704 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17195704 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17195704 | pubmed:pagination | 41-5 | lld:pubmed |
| pubmed-article:17195704 | pubmed:meshHeading | pubmed-meshheading:17195704... | lld:pubmed |
| pubmed-article:17195704 | pubmed:meshHeading | pubmed-meshheading:17195704... | lld:pubmed |
| pubmed-article:17195704 | pubmed:meshHeading | pubmed-meshheading:17195704... | lld:pubmed |
| pubmed-article:17195704 | pubmed:meshHeading | pubmed-meshheading:17195704... | lld:pubmed |
| pubmed-article:17195704 | pubmed:meshHeading | pubmed-meshheading:17195704... | lld:pubmed |
| pubmed-article:17195704 | pubmed:meshHeading | pubmed-meshheading:17195704... | lld:pubmed |
| pubmed-article:17195704 | pubmed:meshHeading | pubmed-meshheading:17195704... | lld:pubmed |
| pubmed-article:17195704 | pubmed:meshHeading | pubmed-meshheading:17195704... | lld:pubmed |
| pubmed-article:17195704 | pubmed:meshHeading | pubmed-meshheading:17195704... | lld:pubmed |
| pubmed-article:17195704 | pubmed:meshHeading | pubmed-meshheading:17195704... | lld:pubmed |
| pubmed-article:17195704 | pubmed:meshHeading | pubmed-meshheading:17195704... | lld:pubmed |
| pubmed-article:17195704 | pubmed:meshHeading | pubmed-meshheading:17195704... | lld:pubmed |
| pubmed-article:17195704 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17195704 | pubmed:articleTitle | Impact of rotavirus infections on outpatient clinic visits in chile. | lld:pubmed |
| pubmed-article:17195704 | pubmed:affiliation | Microbiology and Mycology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile. moryan@med.uchile.cl | lld:pubmed |
| pubmed-article:17195704 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17195704 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:17195704 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
